Related Experiment Video

Updated: Sep 26, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma

Tamotsu Kuroki1, Francesco Trapasso, Sai Yendamuri

  • 1Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, Pennsylvania 19107, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|April 10, 2003
PubMed
Abstract

Insights

Epigenetic silencing of the RASSF1A gene via promoter hypermethylation is common in esophageal squamous cell carcinoma. This silencing correlates with reduced gene expression and advanced tumor stage, suggesting its role in cancer development.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • The RAS association domain family 1A (RASSF1A) gene functions as a tumor suppressor.
  • RASSF1A inactivation by promoter hypermethylation is observed in various cancers.
  • Understanding RASSF1A methylation in esophageal cancer is crucial.

Purpose of the Study:

  • To investigate the promoter methylation status of the RASSF1A gene in esophageal squamous cell carcinoma.
  • To determine the frequency of RASSF1A promoter hypermethylation in esophageal cancer cell lines and primary tumors.

Main Methods:

  • Methylation-specific PCR was employed to analyze RASSF1A promoter methylation.
  • The study included 23 esophageal squamous cell carcinoma cell lines and 48 primary tumors.

Main Results:

  • RASSF1A promoter hypermethylation was detected in 74% of cell lines and 52% of primary tumors.
  • Hypermethylation significantly correlated with loss of RASSF1A mRNA expression (P = 0.007 in cell lines, P = 0.003 in tumors).
  • A significant association was found between RASSF1A hypermethylation and advanced tumor stage (P = 0.009).

Conclusions:

  • Epigenetic silencing of RASSF1A through promoter hypermethylation appears to be a key event in esophageal squamous cell carcinogenesis.
  • RASSF1A hypermethylation may serve as a potential biomarker for esophageal cancer progression.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...